Shahin MS
No ORCID on file
· 1 paper in corpus
nonrandomized-trial
2018
OBJECTIVES: To determine the efficacy and tolerability of sunitinib in recurrent or persistent clear cell ovarian cancer patients. METHODS: All patients had one or two prior regimens with measurable disease. Tumors were at least 50% clear …